MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)

    L. Ramig, R. Macdonald, P. Jiang, H. Hodges, J. Spielman, O. Reed, E. Nauman, C. Bergey, J. Cattiau (New York, USA)

    Objective: Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD. Background: Disordered speech…
  • MDS Virtual Congress 2021

    Evaluating the use of digital biomarkers to test treatment effects on cognition and motor in patients with Lewy Body Dementia

    J. Wang, C. Battioui, A. Mccarthy, X. Dang, H. Zhang, A. Man, J. Kyle, L. Munsie, M. Pugh, K. Biglan (Indianapolis, USA)

    Objective: To evaluate if frequent cognitive and motor tests using an iPad app and a wrist-worn actigraphy watch to track activity and sleep can detect…
  • MDS Virtual Congress 2021

    LOSS OF SPIRAL AXIS FOR DIAGNOSES OF FUNCTIONAL TREMOR

    F. Alonso-Frech, V. Gomez-Mayordomo, A. Baltasar-Corral, M. Hernández-García, R. García-Ramos, E. Lopez-Valdes, A. Fernandez-Revuelta (Madrid, Spain)

    Objective: To investigate whether changes in Arquimedes' spiral can be an objective test for bringing up the inconsistency in patients with functional overlay tremor Background:…
  • MDS Virtual Congress 2021

    The sleep quality and its related factors of essential tremor patients

    JX. Peng, NN. Li, JY. Li, LR. Duan, CL. Chen, R. Peng (Chengdu, China)

    Objective: The objective of the study was to investigate the sleep quality and other sleep disorders among essential tremor (ET) patients and also to explore…
  • MDS Virtual Congress 2021

    Engage-PD: a Physical Activity Coaching Program via Telehealth for people with Parkinson’s Disease – Preliminary results a year after inception.

    C. Macpherson, M. King, H. Shih, J. Rieger, J. Fineman, J. Reid, A. Pacheco, H. Shah, R. Alcalay, L. Quinn (New York City, USA)

    Objective: The purpose of this study was to evaluate effects of a telehealth (TH) coaching program to promote physical activity (PA) in people with Parkinson’s…
  • MDS Virtual Congress 2021

    Atypical presentation of Ataxia telangiectasia masquerading as Parkinson’s Disease

    G. Casinelli, R. Tripathi (Morgantown, USA)

    Objective: NA Background: Parkinson's disease comprises of rest tremor, bradykinesia as well as difficulty with gait and abnormal posture. Certain neurological disorders may mimic Parkinsonism…
  • MDS Virtual Congress 2021

    Clinical and imaging features of idiopathic cerebellar ataxia with anti-cerebellar antibodies

    A. Takekoshi, A. Kimura, N. Yoshikura, T. Shimohata (Gifu, Japan)

    Objective: The current study sought to determine whether autoimmunity can account for some cases of IDCA. Background: Idiopathic cerebellar ataxia (IDCA) is the clinical-based term…
  • MDS Virtual Congress 2021

    Hemichorea as an initial symptom of antibodies against contactin- associated protein-like 2 (CASPR2) encephalitis

    A. Ventura, G. Lopez, MA. Piedrabuena, E. Seminara, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Describe a case of hemichorea as the initial symptom of CASPR2 encephalitis. Background: The clinical spectrum of syndromes associated with CASPR2 is extensive and…
  • MDS Virtual Congress 2021

    Evaluation of the QTc prolongation risk of deutetrabenazine

    F. Schneider, B. Darpo, M. Gutierrez, M. Gordon, L. Rabinovich-Guilatt (Ulm, Germany)

    Objective: To assess QTc prolongation risk of deutetrabenazine and its active metabolites by conducting exposure-QTc interval modeling, and to predict QTc prolongation in both CYP2D6…
  • MDS Virtual Congress 2021

    Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

    B. Dorfman, M. Velickovic, W. Tse (New York, USA)

    Objective: To report on patterns of patients presenting to our center for botulinum toxin injections during the height of the COVID-19 pandemic in New York…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley